Suresh G Nair (Suresh Nair)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Sentinel Lymph Node

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G Nair, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Gruenwald
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, Elizabeth C Dees, Adedayo A Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M Parsons, Timothy R Wassenaar, Jennifer M Suga, Robert D Siegel, William Irvin, Suresh G Nair, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M Safa, Daniel M Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D Bryan Johnson, Daniel R Rhodes, Scott A Tomlins
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. Cancer research communications 3 (7) (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Frank A Sinicrope, Qian Shi, Aurelie Catteau, Graham M Poage, Tyler J Zemla, Bernhard Mlecnik, Al Bowen Benson, Sharlene Gill, Richard M Goldberg, Morton S Kahlenberg, Suresh G Nair, Anthony Frank Shields, Thomas C Smyrk, Jerome Galon, Steven R Alberts
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial. JCO precision oncology 6 (2022)
Michael A Postow, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, James W Smithy, Ellesa Naito, Marina K Cugliari, Vladislav Raber, Omar Eton, Suresh G Nair, Katherine S Panageas, Jedd D Wolchok, Paul B Chapman
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2021)
Frank A Sinicrope, Qian Shi, Thomas C Smyrk, Richard M Goldberg, Steven J Cohen, Sharlene Gill, Morton S Kahlenberg, Suresh G Nair, Anthony F Shield, Balkrishna N Jahagirdar, Sawyer B Jacobson, Nathan R Foster, Michael N Pollak, Steven R Alberts
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer. JNCI cancer spectrum 5 (5) (2021)